6-Fluoro-1H-indole-3-carbonitrile, 95.0%, 250mg

Pomalidomide-C7-COOH, 500mg

2,3-Dihydrobenzo[b][1,4]dioxine-2-carboxamide, 97%, 5g

[(9H-Fluoren-9-ylmethoxycarbonyl)-methyl-amino]-acetic acid, 98.0%, 10g

1-(2-Chloropyridin-4-yl)ethanone, 97.0%, 10g

12-Oxa-2,8,10-triazatetradec-8-enoic acid, 3-carboxy-9-[[(1,1-dimethylethoxy)carbonyl]amino]-13,13-dimethyl-11-oxo-, 1-(9H-fluoren-9-ylmethyl) ester, (3S)-, 97%, 5g

(R)-Methyl 2-(benzylamino)-3-hydroxypropanoate, 95.0%, 25g

4-Chloro-3-fluorophenol>98.0%(GC)(T)5g

3-Methoxysalicylic acid, min. 97%, for synthesis, 25 g, glass packaging

tert-Butyl (3S,4R)-3-(hydroxymethyl)-4-(4-methoxyphenyl)pyrrolidine-1-carboxylate, 95.0%, 250mg

4-Bromo-2-(difluoromethoxy)-1-methoxybenzene, 250mg

(R)-3-Phenylbutanoic acid, 97%, 25g

2,3,4-Trichloropyridine, 95.0%, 25g